Inspira Technologies Oxy B.H.N. Ltd. (IINN): Price and Financial Metrics
IINN Price/Volume Stats
| Current price | $1.39 | 52-week high | $2.70 |
| Prev. close | $1.40 | 52-week low | $0.98 |
| Day low | $1.36 | Volume | 8,600 |
| Day high | $1.47 | Avg. volume | 65,384 |
| 50-day MA | $1.34 | Dividend yield | N/A |
| 200-day MA | $1.42 | Market Cap | 10.84M |
IINN Stock Price Chart Interactive Chart >
Inspira Technologies Oxy B.H.N. Ltd. (IINN) Company Bio
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Latest IINN News From Around the Web
Below are the latest news stories about INSPIRA TECHNOLOGIES OXY BHN LTD that investors may wish to consider to help them evaluate IINN as an investment opportunity.
Inspira Technologies Appoints Dr. Nir as Chief Medical OfficerInspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, has announced the appointment of Dr. Adi Rizansky Nir, PhD to the position of Chief Medical Officer ("CMO"). Dr. Nir brings a wealth of expertise and a distinguished track record in the field of medicine and healthcare administration to the Company. |
Inspira™ Technologies Reports First Quarter 2023 Financial ResultsInspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, announced today its financial results for the first quarter ended March 31, 2023. |
Inspira™ Technologies will Reveal the New ALICE™ Device at the World's Largest Extracorporeal Life Support ConferenceInspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, has announced today it will reveal the new ALICE™ device at the world's largest Extracorporeal Life Support Organization (ELSO) conference, the 34th Annual ELSO Conference in Seattle, Washington, which will be held between the 28th of September and the 1st of October 2023. |
Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon DioxideInspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, today announced the development of the VORTX™ Blood Oxygenator, an Augmented Respiration Technology based on a new breakthrough technological approach, being designed with the intent to imitate the function of the lung, by efficiently saturating the blood with oxygen and removing carbon dioxide. |
Inspira Technologies and Genius Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)RedChip Companies will air new interviews with Inspira Technologies OXY B.H.N. Ltd. (Nasdaq:IINN, IINNW) and Genius Group Limited (NYSE American:GNS) on The RedChip Money Report® on Bloomberg TV, this Saturday, May 6, at 7 p.m. Eastern Time (ET). |
IINN Price Returns
| 1-mo | 6.11% |
| 3-mo | -12.37% |
| 6-mo | 26.36% |
| 1-year | -14.72% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | 7.75% |
| 2022 | -68.99% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...